Philadelphia Mesothelioma Lawyers: Study Reports that Survival Rates May Not Be Linked to Treatment Type

Some new information from Australia provides interesting insight into survival rates for mesothelioma patients.  The Asbestos Diseases Research Institute and Sydney Medical School conducted a study in an area of the country long known for its asbestos mining industry.   More than 900 patients diagnosed with pleural mesothelioma were specifically analyzed for this research study.

The good news is that study findings reveal that survival rates for those suffering from pleural mesothelioma have increased.   Specifically, criteria for improved survival include patients diagnosed under the age of 70, female patients, those with epithelioid histology, decreased neutrophil/lymphocyte ratio and normal hemoglobin.   These findings were consistent with other similarly situated research for survival rates of people with pleural mesothelioma.

Another interesting and more surprising finding of the study shows that treatment for mesothelioma may not have as much to do with a patient’s increased survival rate as one would surmise.  The Australian study confirmed that patients who specifically underwent two treatments, extrapleural pneumonectomy (EPP) and pemetrexed-based chemotherapy, experienced longer survival rates.  However, in addition researchers identified another group of patients with a high survival rate who did not undergo those types of treatments.  In fact, a large majority of long-term mesothelioma survivors were not part of either of these treatment plans which raises the question: What exactly is the most effective way to treat mesothelioma?

This study provides valuable information to researchers and medical professionals regarding precisely what is the most valuable type of treatment options that will maximize a patient’s chance of survival.

For More Information on Treatment Options for Mesothelioma Contact the Philadelphia Asbestos Lawyers of Brookman, Rosenberg, Brown & Sandler

Philadelphia mesothelioma lawyers at Brookman, Rosenberg, Brown & Sandler stay current with relevant information that may impact local residents dealing with mesothelioma and other asbestos-caused illnesses.  Our lawyers represent clients in both New Jersey and Pennsylvania and evaluate mesothelioma cases and asbestos claims at no cost to you. Call our Center City Philadelphia office today at 800-369-0899 or contact us online.

Recent Posts

Are Oil Refinery Workers at Risk for Asbestos Exposure?

Occupational hazards are associated with working at an oil refinery, from the risk of fires or explosions to being exposed…

2 weeks ago

Atlantic City School Has Asbestos: Parents, Teachers Were Not Notified

The recurring pattern of poor communication plagues both the City of Atlantic City and the Atlantic City Public Schools system…

3 weeks ago

How Can I Identify Asbestos Siding?

Asbestos shingle siding dates back to 1907, and the National Board of Fire Underwriters later endorsed it for its resistance…

2 months ago

Can I Sue for Compensation if I Have Mesothelioma?

Mesothelioma is an incurable disease that will have an immeasurable impact on both the person who was diagnosed and their…

3 months ago

Can Surgery Treat My Mesothelioma?

Depending on the kind of mesothelioma you have and whether it has progressed, treatment options may alleviate symptoms and extend…

4 months ago

Are Young Adults Getting Mesothelioma?

Mesothelioma is an aggressive form of cancer that is caused by exposure to asbestos. In most cases, mesothelioma affects people…

5 months ago
Attorney Advertising Materials. Cary Sandler is responsible for the content of this website. This website is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of a lawyer/client relationship.

Disclaimer: The case results should not create an unjustified expectation that similar results can be obtained for others without regard to the specific factual and legal circumstances of your case.

© 2019 Brookman, Rosenberg, Brown & Sandler. | All Rights Reserved.
LIVE CHAT